Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Cash flows from operating activities:
Net income	$ 260,240	$ 229,730
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	37,801	36,283
Stock-based compensation expense	64,655	67,113
Deferred income taxes	7,466	1,122
Loss on retirement or write-off of long-lived assets	381	74
Other non-cash adjustments	812	2,276
Restructuring costs	0	1,959
Net change in operating assets and liabilities:
Accounts receivable	(99,465)	(67,558)
Inventories	(48,310)	(23,223)
Prepaid wafers	58,296	36,654
Other assets	(4,080)	11,682
Accounts payable and other accrued liabilities	17,749	(32,201)
Income taxes payable	18,435	8,598
Acquisition-related liabilities	0	(21,361)
Net cash provided by operating activities	313,980	251,148
Cash flows from investing activities:
Maturities and sales of available-for-sale marketable securities	25,904	23,418
Purchases of available-for-sale marketable securities	(117,505)	(53,525)
Purchases of property, equipment and software	(19,347)	(30,593)
Investments in technology	(225)	(57)
Net cash used in investing activities	(111,173)	(60,757)
Cash flows from financing activities:
Net proceeds from the issuance of common stock	15,433	610
Repurchase of stock to satisfy employee tax withholding obligations	(33,538)	(16,851)
Repurchase and retirement of common stock	(161,022)	(136,003)
Net cash used in financing activities	(179,127)	(152,244)
Net increase in cash and cash equivalents	23,680	38,147
Cash and cash equivalents at beginning of period	502,764	445,784
Cash and cash equivalents at end of period	$ 526,444	$ 483,931